Selandia Baru - Inggris - Medsafe (Medicines Safety Authority)

astrazeneca limited - dapagliflozin propanediol monohydrate 6.15mg equivalent to dapagliflozin 5 mg;  ; metformin hydrochloride 1000mg (with 0.5% magnesium stearate);   - modified release tablet - 5mg/1000mg - active: dapagliflozin propanediol monohydrate 6.15mg equivalent to dapagliflozin 5 mg   metformin hydrochloride 1000mg (with 0.5% magnesium stearate)   excipient: carmellose calcium colloidal silicon dioxide crospovidone hypromellose lactose magnesium stearate microcrystalline cellulose opadry pink 85f94592 - glycaemic control xigduo xr is indicated in adults with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycemic control when treatment with both dapagliflozin and metformin is appropriate (see sections 5.1 and 4.4 for available data on the combination therapy). prevention of hospitalisation for heart failure dapagliflozin is indicated in adults with type 2 diabetes mellitus and established cardiovascular disease or risk factors for cardiovascular disease to reduce the risk of hospitalisation for heart failure (see section 5.1 pharmacodynamic properties – clinical efficacy and safety). prevention of new or worsening nephropathy dapagliflozin is indicated in adults with type 2 diabetes mellitus and established cardiovascular disease or risk factors for cardiovascular disease for the prevention of new or worsening nephropathy (see section 5.1 pharmacodynamic properties – clinical efficacy and safety).

Australia - Inggris - Department of Health (Therapeutic Goods Administration)

neolife international pty ltd - glycine max, quantity: 225 mg (equivalent: linolenic acid, qty 16.65 mg); triticum aestivum, quantity: 150 mg (equivalent: gluten, qty 0 mg); triticum aestivum, quantity: 10 mg (equivalent: gluten, qty 0.004 mg); oryza sativa, quantity: 300 mg; oryza sativa, quantity: 10 mg; mixed (high-alpha type) tocopherols concentrate, quantity: 2 mg - capsule, soft - excipient ingredients: gelatin; yellow beeswax; titanium dioxide; chlorophyllin-copper complex; purified water; glycerol - antioxidant/reduce free radicals formed in the body ; maintain/support body metabolism/metabolic rate ; maintain/support energy production ; maintain/support eye health ; maintain/support healthy teeth ; anti-inflammatory/relieve inflammation ; maintain/support connective tissue health ; helps enhance/promote bone health ; maintain/support bone health ; helps enhance/promote healthy joint function ; maintain/support joint health ; maintain/support cardiovascular system health ; maintain/support healthy cardiovascular system function ; maintain/support heart health ; maintain/support immune system health ; maintain/support healthy immune system function ; maintain/support muscle health ; maintain/support muscle function ; helps maintain/support cellular uptake of (state vitamin/mineral/nutrient) ; helps prevent dietary (state vitamin/mineral/nutrient) deficiency ; maintain/support brain function ; maintain/support nervous system health ; maintain/support nervous system function

Selandia Baru - Inggris - Medsafe (Medicines Safety Authority)

ipca pharma (nz) pty limited - amlodipine besilate 13.88mg equivalent to 10 mg amlodipine;   - tablet - 10 mg - active: amlodipine besilate 13.88mg equivalent to 10 mg amlodipine   excipient: calcium hydrogen phosphate dihydrate colloidal silicon dioxide magnesium stearate microcrystalline cellulose sodium starch glycolate - amlodipine is indicated for the first line treatment of hypertension and can be used as the sole agent to control blood pressure in the majority of patients. patients not adequately controlled on a single antihypertensive agent may benefit from the addition of amlodipine, which has been used in combination with a thiazide diuretic, beta adrenoceptor blocking agent, or an angiotensin-converting enzyme inhibitor.

Selandia Baru - Inggris - Medsafe (Medicines Safety Authority)

dr reddy's new zealand limited - amlodipine besilate 13.869mg equivalent to 10 mg amlodipine anhydrous base;   - tablet - 10 mg - active: amlodipine besilate 13.869mg equivalent to 10 mg amlodipine anhydrous base   excipient: magnesium stearate microcrystalline cellulose

Selandia Baru - Inggris - Medsafe (Medicines Safety Authority)

multichem nz limited - amlodipine besilate 13.87mg equivalent to 10 mg amlodipine - tablet - 10 mg - active: amlodipine besilate 13.87mg equivalent to 10 mg amlodipine excipient: colloidal silicon dioxide magnesium stearate mannitol microcrystalline cellulose sodium starch glycolate

Selandia Baru - Inggris - Medsafe (Medicines Safety Authority)

rex medical ltd - amlodipine besilate 13.87mg equivalent to 10.0 mg amlodipine base - tablet - 10 mg - active: amlodipine besilate 13.87mg equivalent to 10.0 mg amlodipine base excipient: calcium hydrogen phosphate dihydrate colloidal silicon dioxide magnesium stearate microcrystalline cellulose sodium starch glycolate - amlodipine is indicated for the first line treatment of hypertension and can be used as the sole agent to control blood pressure in the majority of patients. patients not adequately controlled on a single antihypertensive agent may benefit from the addition of amlodipine, which has been used in combination with a thiazide diuretic, beta adrenoceptor blocking agent, or an angiotensin-converting enzyme inhibitor.

Selandia Baru - Inggris - Medsafe (Medicines Safety Authority)

norton healthcare limited (nz) - amlodipine besilate 13.888mg equivalent to 10 mg amlodipine - tablet - 10 mg - active: amlodipine besilate 13.888mg equivalent to 10 mg amlodipine excipient: calcium hydrogen phosphate magnesium stearate microcrystalline cellulose sodium starch glycolate

Selandia Baru - Inggris - Medsafe (Medicines Safety Authority)

ipca pharma (nz) pty limited - amlodipine besilate 6.935mg equivalent to 5 mg amlodipine;   - tablet - 5 mg - active: amlodipine besilate 6.935mg equivalent to 5 mg amlodipine   excipient: calcium hydrogen phosphate dihydrate colloidal silicon dioxide magnesium stearate microcrystalline cellulose sodium starch glycolate - amlodipine is indicated for the first line treatment of hypertension and can be used as the sole agent to control blood pressure in the majority of patients. patients not adequately controlled on a single antihypertensive agent may benefit from the addition of amlodipine, which has been used in combination with a thiazide diuretic, beta adrenoceptor blocking agent, or an angiotensin-converting enzyme inhibitor.

Selandia Baru - Inggris - Medsafe (Medicines Safety Authority)

dr reddy's new zealand limited - amlodipine besilate 6.935mg equivalent to 5 mg amlodipine anhydrous base;   - tablet - 5 mg - active: amlodipine besilate 6.935mg equivalent to 5 mg amlodipine anhydrous base   excipient: magnesium stearate microcrystalline cellulose

Selandia Baru - Inggris - Medsafe (Medicines Safety Authority)

multichem nz limited - amlodipine besilate 6.93mg equivalent to 5 mg amlodipine - tablet - 5 mg - active: amlodipine besilate 6.93mg equivalent to 5 mg amlodipine excipient: colloidal silicon dioxide magnesium stearate mannitol microcrystalline cellulose sodium starch glycolate